TARO

Taro Pharmaceutical Indu... (TARO)

Taro Pharmaceutical Industries Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:TARO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	21:10	PR Newswire (US)	Taro Shareholders Approve Merger with Sun Pharma	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/23	21:01	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/23	20:50	PR Newswire (US)	Taro Shareholders Approve Merger with Sun Pharma	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/23	20:50	PR Newswire (Canada)	Taro Shareholders Approve Merger with Sun Pharma	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/23	20:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/21	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/21	06:00	Business Wire	Taro Provides Results for Year Ended March 31, 2024	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/15	22:00	Business Wire	Taro to Release Full Year Results on May 20, 2024	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/14	21:20	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/08	22:28	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/05/08	22:07	Business Wire	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/04/15	21:00	Business Wire	Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/03/11	19:19	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/02/15	22:36	Edgar (US Regulatory)	Form SC 13E3 - Going private transaction by certain issuers	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/31	03:18	PR Newswire (US)	Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/30	21:00	PR Newswire (US)	Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/26	23:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/26	07:06	Business Wire	Taro Provides Results for December 31, 2023	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/20	06:15	Business Wire	Taro to Release Third Quarter Results on January 25, 2024	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/18	06:36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/18	06:35	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/18	06:30	PR Newswire (US)	Taro Announces Merger Agreement with Sun Pharma	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/18	06:30	PR Newswire (Canada)	Taro Announces Merger Agreement with Sun Pharma	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2024/01/05	06:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2023/12/12	06:31	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2023/12/12	06:30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2023/11/18	06:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2023/10/27	22:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2023/10/27	06:00	Business Wire	Taro Provides Results for September 30, 2023	NYSE:TARO	Taro Pharmaceutical Industries Ltd
2023/10/20	05:30	Business Wire	Taro to Release Second Quarter Results on October 26, 2023	NYSE:TARO	Taro Pharmaceutical Industries Ltd